Events

Online event: Research security risks: insider threats by EARMA
OCT
Mon
21
10:30 - 12:00

This was 6 months ago

Location

Online

Programmes
Security Digital, Industry & Space EDF

This event is the first in a three-event series promoting European cooperation in addressing research security challenges hosted by EARMA.

Each session will provide practical support to research managers including discussion of case studies, signposting to publicly available tools and resources, and commercially available products.

Event details:

  • Date: Monday 21st October
  • Time: 10:30 – 12:00 (GMT+2)
  • Click here to book!

 

Here you can find information about the next events in this series:

2) Resources for managing research security risks (November 15th 2024)

3) Products to support research security management (December 12th 2024)

 

For more information on these events and the full agenda, please access the dedicated event page. 

 

 

myOverview - sign up for personalised information

We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).

Stay informed about what matters to you. By signing up, you can opt in for e-mail notifications and get access to a personalised dashboard that groups all news updates and event announcements in your domain(s).

Only for stakeholders located in Flanders

Event calendar

 

Testimonial

image of BEAT-AF - Ground-Breaking Electroporation-based intervention for Atrial Fibrillation treatment

BEAT-AF - Ground-Breaking Electroporation-based intervention for Atrial Fibrillation treatment

The Horizon2020 project BEAT-AF brings together 9 European renowned clinical centres in France, Belgium, Czechia, Germany and Austria. Together, the consortium strives to revolutionize Atrial Fibrillation (AF) treatment through catheter ablation and contribute to decrease the huge burden of AF in Europe. The BEAT-AF project kicked off in 2021 and will run until 2026. The department of electrophysiology of the AZ Sint-Jan Hospital in Bruges is partner in the project and has so far contributed to the pre-clinical development, the first in man studies and first registries of the revolutionary AF treatment put forward by the consortium. The first pilot studies show that the treatment is safe, effective and efficient.